WallStreetZenWallStreetZen

NASDAQ: TRVI
Trevi Therapeutics Inc Stock Ownership - Who owns Trevi Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Trevi Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Lisa DelfiniChief Financial Officer2023-10-112,292$0.51
$1.17kBuy
Lisa DelfiniChief Financial Officer2023-10-11785$2.02
$1.59kSell
Lisa DelfiniChief Financial Officer2023-09-11711$2.20
$1.56kSell
Lisa DelfiniChief Financial Officer2023-09-112,291$0.51
$1.17kBuy
Lisa DelfiniChief Financial Officer2023-08-112,292$0.51
$1.17kBuy
Lisa DelfiniChief Financial Officer2023-08-11682$2.36
$1.61kSell
Lisa DelfiniChief Financial Officer2023-07-11687$2.34
$1.61kSell
Lisa DelfiniChief Financial Officer2023-07-112,292$0.51
$1.17kBuy
Farrell SimonChief Commercial Officer2023-06-206,250$0.51
$3.19kBuy
Lisa DelfiniChief Financial Officer2023-06-122,291$0.51
$1.17kBuy

1 of 2

TRVI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRVI insiders and whales buy or sell their stock.

TRVI Shareholders

What type of owners hold Trevi Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Peter W. Sonsini25.10%17,308,374$45.87MInsider
Anthony A. Florence Jr.25.10%17,308,374$45.87MInsider
Carmen Chang25.10%17,308,374$45.87MInsider
Ali Behbahani25.10%17,308,374$45.87MInsider
Scott D. Sandell25.10%17,308,374$45.87MInsider
Mohamad Makhzoumi25.10%17,308,374$45.87MInsider
Paul Edward Walker25.10%17,308,374$45.87MInsider
Forest Baskett23.72%16,359,426$43.35MInsider
Nea Management Company LLC16.49%11,370,376$30.13MInstitution
New Enterprise Associates 16 LP15.11%10,421,428$27.62MInsider

1 of 3

TRVI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRVI22.22%77.78%Net Buying
AGEN63.15%36.85%Net BuyingNet Buying
VERU40.81%28.47%
OMER43.03%6.69%Net Buying
ELEV53.13%24.22%Net SellingNet Selling
View Top Biotech Stocks

Trevi Therapeutics Stock Ownership FAQ

Who owns Trevi Therapeutics?

Trevi Therapeutics (NASDAQ: TRVI) is owned by 75.75% institutional shareholders, 265.19% Trevi Therapeutics insiders, and 0.00% retail investors. Peter W. Sonsini is the largest individual Trevi Therapeutics shareholder, owning 17.31M shares representing 25.10% of the company. Peter W. Sonsini's Trevi Therapeutics shares are currently valued at $43.96M.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.